Skip to main content
. 2021 Apr 21;97:107702. doi: 10.1016/j.intimp.2021.107702

Fig. 5.

Fig. 5

Changes of peripheral blood lymphocyte subsets (median value) in Favipiravir group and Control group. (A) CD3+ Lymphocyte percentage (B) CD3+ Lymphocyte count (C) CD4+ Lymphocyte percentage (D) CD4+ Lymphocyte count (E) CD8+ Lymphocyte percentage (F) CD8+ Lymphocyte count.